Table 3. Benchmark etoposide cytotoxicity in EWS cell lines.
| Cell line | Efficacy (EC50) µM | Sensitivity24 hrs % dead cells per nM morpholino (r2) |
Fraction dead cells at 24 hours (FA24 hs)† |
|---|---|---|---|
| HEK293 (control) | 0.73 | 0.068 (0.895) | 0.16 ± 0.01 |
| TC-32 | 0.64 | 0.078 (0.900) | 0.26 ± 0.05* |
| CHLA-9 | 0.43 | 0.117 (0.889) | 0.32 ± 0.03* |
| CHLA-10 | 0.32 | 0.156 (0.915) | 0.41 ± 0.05* |
†Fraction Dead Cells at 24 hours (FA24 hrs) represents the activity of the agent and is calculated for individual cell lines using the fraction of cells lost among 5 biological replicates at the most potent concentration of etoposide, corrected to the average fraction of cells lost using a DMSO vehicle control only; All replicates were measured on the same 96-well tray and were seeded with an identical number of starting cells, 24 hours prior to etoposide treatment (see methods).
*p < 0.05, based on paired student t-test comparing mean corrected activity (FA24 hrs) at 24 hours.